Soru

Zorluk: ZorOrdering Laboratory Tests

A 24-year-old woman comes to the clinic for evaluation of a lifelong history of heavy menstrual bleeding and frequent epistaxis that often takes more than 15 minutes to stop. She recently underwent a tooth extraction that was complicated by excessive bleeding requiring surgical packing. She takes no medications and has no other medical conditions. Her family history is notable for her mother having a 'bleeding problem' and undergoing a hysterectomy at age 35 for severe menorrhagia. Physical examination reveals a few scattered ecchymoses on her upper and lower extremities. A complete blood count shows a hemoglobin of 11.2 g/dL and a platelet count of 250,000/mm³. Coagulation studies demonstrate a normal prothrombin time (PT) and a mildly prolonged activated partial thromboplastin time (aPTT) of 42 seconds (reference: 25-35 seconds). Which of the following is the most appropriate next step in laboratory evaluation?

  1. Measurement of von Willebrand factor antigen, von Willebrand factor activity, and factor VIII levelsCevap
  2. B
    Mixing study of the activated partial thromboplastin time
  3. C
    Testing for lupus anticoagulant and anti-beta-2-glycoprotein I antibodies
  4. D
    Measurement of specific factor VIII and factor IX inhibitor titers
  5. E
    Platelet aggregometry testing

Cevap

Measurement of von Willebrand factor antigen, von Willebrand factor activity, and factor VIII levels
The patient's clinical presentation of lifelong mucosal bleeding (epistaxis, heavy menstrual bleeding, excessive bleeding after tooth extraction), a family history suggestive of an autosomal dominant bleeding disorder, and a normal PT with a mildly prolonged aPTT strongly point to von Willebrand disease (vWD). The most appropriate initial laboratory evaluation to establish this diagnosis is a vWD panel, which includes measurement of von Willebrand factor (vWF) antigen, vWF activity, and factor VIII levels. In vWD, the aPTT may be normal or mildly prolonged because vWF serves as a carrier protein that stabilizes factor VIII in the circulation; a deficiency in vWF leads to accelerated clearance of factor VIII, thereby prolonging the intrinsic pathway coagulation time.

Adım Adım Çözüm

1
Analyze the patient's clinical presentation.
The patient has a lifelong history of mucocutaneous bleeding (epistaxis, menorrhagia, excessive bleeding after dental procedures) and a family history suggestive of an autosomal dominant inheritance pattern.
Identifying the type of bleeding (mucocutaneous vs. deep tissue/joint) and the inheritance pattern helps significantly narrow the differential diagnosis.
2
Evaluate the laboratory findings.
The patient has a normal platelet count, a normal PT, and a mildly prolonged aPTT.
Normal platelets rule out quantitative platelet disorders. A prolonged aPTT with a normal PT indicates an abnormality within the intrinsic coagulation pathway (Factors VIII, IX, XI, XII).
3
Synthesize the findings to formulate a likely diagnosis.
The combination of mucocutaneous bleeding and a prolonged aPTT is classic for von Willebrand disease (vWD), as von Willebrand factor acts as a carrier protein that stabilizes factor VIII.
A deficiency in von Willebrand factor leads to the accelerated clearance of factor VIII, which causes the mildly prolonged aPTT.
4
Select the most appropriate diagnostic test based on pre-test probability.
A specific vWD panel (vWF antigen, vWF activity, and factor VIII levels) is indicated to confirm the diagnosis.
Given the exceptionally high clinical pre-test probability for vWD, proceeding directly to the specific confirmatory laboratory panel is the most appropriate and cost-effective next step.

Anahtar Kavram

In a patient presenting with lifelong mucocutaneous bleeding, a positive family history, and a mildly prolonged aPTT, von Willebrand disease is the most likely diagnosis. The initial laboratory evaluation should directly assess von Willebrand factor (vWF) antigen, vWF activity (such as ristocetin cofactor activity), and factor VIII levels.

DisorderPlatelet CountPTaPTT
von Willebrand DiseaseNormalNormalNormal or Prolonged
Hemophilia A/BNormalNormalProlonged
Quantitative Platelet DisorderDecreasedNormalNormal
Antiphospholipid SyndromeNormal/DecreasedNormalProlonged (in vitro)
Bu soruyu puanla